ArticleCancer medicine2017

Development and characterization of anti-glycopeptide monoclonal antibodies against human podoplanin, using glycan-deficient cell lines generated by CRISPR/Cas9 and TALEN.

Mika K Kaneko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.